-
CXO head companies plan to build new bases overseas to accelerate the process of pharmaceutical innovation
Time of Update: 2022-08-15
[PharmaNet Corporate News] WuXi AppTec, the leading CXO company, recently announced that the company plans to establish a R&D and production base in Singapore, and expects to invest a total of 2 billion Singapore dollars (about 1.
-
From June 1st, Lu Xiangyi will resume work and production at full speed!
Time of Update: 2022-08-15
On the morning of May 31, at a press conference on the prevention and control of the new coronary pneumonia epidemic in Shanghai, Zong Ming, deputy mayor of Shanghai, said that from June 1, Shanghai will enter the third stage, that is, to fully restore the normal production and living order in the city stage .
-
Congratulations to Tianjin Bohai Xinmao for winning the "June Pharmaceutical Network's June Pharmaceutical Machine Event Enterprise Live Broadcasting Award"!
Time of Update: 2022-08-15
According to reports, Tianjin Bohai Xinmao is committed to the research and development and production of machinery in the fields of pharmaceuticals, food and chemicals, and provides high-quality pre-sales and after-sales services Tianjin Bohai Xinmao part of the live broadcast So what kind of company is this?
-
The pace of global commercialization of this pharmaceutical company's innovative drugs continues to accelerate!
Time of Update: 2022-08-15
Development, production and commercialization interests in 17 countries in the Middle East and North Africa, including the United Arab Emirates, Saudi Arabia, Egypt, Kuwait, Oman, Bahrain, [Pharmaceutical Network Enterprise News] Recently, Huadong Medicine announced that it has reached a strategic cooperation with Gulf Pharmaceutical Industries PJSC (JULPHAR) (hereinafter referred to as "Julphar"), a Middle Eastern company.
-
This pharmaceutical company accounted for one-fifth of the 16 large-scale mergers and acquisitions in the first half of the year
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] In order to cope with problems such as the imminent expiration of original research drugs, patent cliffs, intensified competition in the industry, and declining profits of generic drugs, many large pharmaceutical companies in recent years have begun to strengthen their research and development pipelines through continuous mergers and acquisitions.
-
Pick up before 12:00am and deliver before 7:00pm!
Time of Update: 2022-08-15
Hardware equipment, in order to respond to the surge in demand for traditional Chinese medicine and improve the efficiency and quality of traditional Chinese medicine preparation, Taiyang Shukang Pharmaceutical introduced the intelligent dispensing system of Donghua original traditional Chinese medicine, allowing the intelligent dispensing method to further enhance the service capacity of traditional Chinese medicine Taiyang Shukang Pharmaceutical Decoction Center was completed and put into operation in 2015.
-
Renfu Pharmaceutical's new indication for remazolam besylate for injection is approved, which will bring positive impact to the company
Time of Update: 2022-08-15
. It is reported that in addition to the approval of the new indications of remazolam besylate for injection recently, Renfu Medicine, the company's holding subsidiary, Yichang Renfu, has also received the "Drug Clinical Application" for RFUS-144 injection approved and issued by the State Drug Administration.
-
Sanofi's Sarclisa combination therapy has significant efficacy in the treatment of multiple myeloma
Time of Update: 2022-08-15
The trial is evaluating the addition of the CD38-targeting antibody Sarclisa (isatuximab) to the proteasome inhibitor Kyprolis (carfilzomib, cardinal) in patients with relapsed multiple myeloma (MM) who have received 1-3 prior anti-myeloma treatments.
-
good news!
Time of Update: 2022-08-15
By strengthening the research and development and innovation of core technologies, with advanced production equipment, strict quality management, and more thoughtful services, it will improve and develop together with pharmaceutical manufacturers!Looking forward to the future, Bolang Machinery said that it will continue to make progress.
-
Du Fu Instrument Factory has been recognized and affirmed, and won the "June Pharmaceutical Network Enterprise Live Broadcasting Award"!
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] Recently, Zhengzhou Dufu Instrument Factory (hereinafter referred to as: Dufu Instrument Factory) participated online in the zyzhan June pharmaceutical machin
-
Another drug of Hengrui has been approved for clinical trials, and the company has received good news since June
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] On June 15, Hengrui Pharmaceutical issued an announcement that the company's SHR4640 tablets obtained the "Drug Clinical Trial Approval Notice" approved and issued by the State Food and Drug Administration.
-
The prevention and control of cardiovascular and cerebrovascular diseases cannot be relaxed for a moment!
Time of Update: 2022-08-15
Zhongyuan Oilfield Health Hut Lvde Real Estate Health Hut [Pharmaceutical Network Enterprise News] After the summer, the temperature rises suddenly, the heat is unbearable, and cardiovascular and cerebrovascular diseases have also entered a period of high incidence .
-
This pharmaceutical company has already reviewed 12 varieties in 2022, and a total of 36 varieties have been selected in the first seven batches of centralized procurement
Time of Update: 2022-08-15
Recently, the good news of the approval of Pemetrexed disodium for injection of Class 4 generic drugs of Kelun Pharmaceutical Co. Pemetrexed disodium for injection is a metabolite with huge market space .
-
Sanofi's "Slimming Program" Continues, 17 Drugs Sold
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] In order to better survive and develop in the competition, many pharmaceutical companies are currently focusing on their main business and divesting some busi
-
The new delisting regulations have landed!
Time of Update: 2022-08-15
After the disclosure of the 2021 annual report, more than 40 companies in the Shanghai and Shenzhen stock exchanges have reached a mandatory delisting, setting a record high for A-shares . A few days
-
List Revealed!
Time of Update: 2022-08-15
Suzhou Ruiqi won the "Excellence Award for Enterprise Live Broadcasting at the Pharmaceutical Network and Medicine Machine Event" Facing the future, the company said that it will continue to uphold the business philosophy of safety and service, and is willing to provide a fresh and clean working environment for the cause of environmental protection and for more laboratory workers!
-
This pharmaceutical equipment company's performance in the first half of the year is positive!
Time of Update: 2022-08-15
Among them, in the pharmaceutical equipment industry, there is also a company that firstly released an announcement of good results from January to June this year, namely Tofflon [Pharmaceutical Network Enterprise News] Recently, listed companies are gradually disclosing their performance forecasts for the first half of 2022.
-
Good news｜ Bailinke won the "Excellent Service Provider of Biomedical Industry"
Time of Update: 2022-08-15
It is committed to continuously providing customers with high-quality innovative products and solutions, and creating an efficient, safe and competitive biopharmaceutical supply chain ecosystem ” Bailinke is a high-tech group enterprise that provides process solutions for life sciences, focusing on key process equipment and consumables in the production of recombinant protein drugs, vaccines, antibody drugs, cell therapy, gene therapy and other biological products.
-
NMN can regulate lipid metabolism and improve various chronic diseases caused by obesity
Time of Update: 2022-08-15
Recently, Professor Mika Kivimöki and her team from University College London, UK, based on clinical research data of more than 100,000 people, found that obesity is closely related to 21 diseases such as cardiovascular metabolism, digestion, respiratory, neurological, musculoskeletal and infectious diseases.
-
Build a solid line of defense for the grassroots!
Time of Update: 2022-08-15
Donghuayuan Smart Health Cabin solution through the "Internet +" innovative health service platform, with the concept of disease prevention and early treatment, through modern Internet technology, information integrated management platform and a series of professional medical testing equipment, to provide people with Self-service physical examination, establish health records for everyone and update and track management in real time .
